Back to Urology
Urologyv1998Evidence-Based

Percent Free PSA

Percent free PSA = (free PSA / total PSA) × 100. In the total PSA 4-10 ng/mL range: >25% low, 10-25% intermediate, <10% high probability of prostate cancer on biopsy.

Clinical Input Parameters

ng/mL
Range: 0.01 — 50 ng/mL
ng/mL
Range: 0.1 — 100 ng/mL
Clinical Assessment
Awaiting Parameters
pct free
—%
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Percent Free PSA is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within urology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

%fPSA = (free / total) × 100.

Clinical Pearls & Practice Notes

  • Most discriminating when total PSA is 4-10 ng/mL.

Evidence & Literature Citations

  1. Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. JAMA. 1998;279(19):1542-1547.

Score Interpretation Ranges

Low25.1 – 100 pts

Low probability

Intermediate10 – 25 pts

Intermediate probability

High0 – 9.9 pts

High probability

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.